/

Droxidopa

CAS 23651-95-8

Overview

Droxidopa is used to treat neurogenic orthostatic hypotension (lightheadedness, dizziness, or fainting) caused by primary autonomic failure (eg, Parkinson's disease, multiple system atrophy, and pure autonomic failure), dopamine beta-hydroxylase deficiency, and non-diabetic autonomic neuropathy

Anant Labs manufacture and furnish high quality Droxidopa impurities for global markets. Our Droxidopa EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.

Active Pharmaceutical Ingredient

Chemical structure of Droxidopa

Droxidopa

CAS: 23651-95-8
Mol. Formula: C₉H₁₁NO₅
Mol. Weight: 213.189

Impurities (8)

Chemical structure of DL-threo-Droxidopa

DL-threo-Droxidopa

Cat. No.: ANT-DRP-05
CAS: 3916-18-5
Mol. Formula: C₉H₁₁NO₅
Mol. Weight: 213.19

Chemical structure of Droxidopa - API

Droxidopa - API

Cat. No.: ANT-DRP-00
CAS: 23651-95-8
Mol. Formula: C₉H₁₁NO₅
Mol. Weight: 213.19

Chemical structure of Droxidopa Benzaldehyde Compound

Droxidopa Benzaldehyde Compound

Cat. No.: ANT-DRP-006
CAS: 5447-02-9
Mol. Formula: C₂₁H₁₈O₃
Mol. Weight: 318.4

Chemical structure of Droxidopa Impurity 1

Droxidopa Impurity 1

Cat. No.: ANT-DRP-01
CAS: 13023-73-9
Mol. Formula: C₈H₈O₄
Mol. Weight: 168.15

Chemical structure of Droxidopa Impurity 2

Droxidopa Impurity 2

Cat. No.: ANT-DRP-02
CAS: 5707-55-1
Mol. Formula: C₈H₈O₃
Mol. Weight: 152.15

Chemical structure of Droxidopa Impurity 3

Droxidopa Impurity 3

Cat. No.: ANT-DRP-03
CAS: 51829-98-2
Mol. Formula: C₉H₁₁NO₅
Mol. Weight: 213.19

Chemical structure of Droxidopa Racemic standard

Droxidopa Racemic standard

Cat. No.: ANT-DRP-007
CAS: 51829-99-3
Mol. Formula: C₉H₁₂ClNO₅
Mol. Weight: 249.65

Chemical structure of Piperonal impurity 1

Piperonal impurity 1

Cat. No.: ANT-DRP-04
CAS: 120-57-0
Mol. Formula: C₈H₆O₃
Mol. Weight: 150.13